KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Novavax (NVAX) over the last 6 years, with Sep 2025 value amounting to $168.2 million.

  • Novavax's Shares Outstanding (Diluted Average) rose 5.09% to $168.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.2 million, marking a year-over-year increase of 5.09%. This contributed to the annual value of $152.2 million for FY2024, which is 51.03% up from last year.
  • As of Q3 2025, Novavax's Shares Outstanding (Diluted Average) stood at $168.2 million, which was down 5.19% from $177.4 million recorded in Q2 2025.
  • Novavax's 5-year Shares Outstanding (Diluted Average) high stood at $177.6 million for Q1 2025, and its period low was $73.0 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $152.2 million (2024), whereas its average is $139.6 million.
  • Data for Novavax's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 62.39% (in 2024) over the last 5 years.
  • Over the past 5 years, Novavax's Shares Outstanding (Diluted Average) (Quarterly) stood at $74.4 million in 2021, then climbed by 5.08% to $78.2 million in 2022, then increased by 28.89% to $100.8 million in 2023, then skyrocketed by 51.03% to $152.2 million in 2024, then rose by 5.09% to $168.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $168.2 million in Q3 2025, compared to $177.4 million in Q2 2025 and $177.6 million in Q1 2025.